{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:38:58Z","timestamp":1792251538797,"version":"4.4.0"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health, USA","doi-asserted-by":"publisher","award":["1R15DK112172-02"],"award-info":[{"award-number":["1R15DK112172-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>To identify naturally occurring variants of IAPP capable of inhibiting the aggregation\nof human IAPP and protecting living cells from the toxic effects of human IAPP.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The loss of insulin-producing \u03b2-cells and the overall progression of type 2 diabetes\nappears to be linked to the formation of toxic human IAPP (hIAPP, Islet Amyloid Polypeptide,\namylin) amyloid in the pancreas. Inhibiting the initial aggregation of hIAPP has the potential to\nslow, if not stop entirely, the loss of \u03b2-cells and halt the progression of the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To identify and characterize naturally occurring variants of IAPP capable of inhibiting\nhuman IAPP aggregation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Synthetic human IAPP was incubated with synthetic IAPP variants identified from natural\nsources under conditions known to promote amyloid-based aggregation. To identify IAPP\nvariants capable of inhibiting human IAPP aggregation, Thioflavin T-binding fluorescence, atomic\nforce microscopy, and cell-rescue assays were performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> While most IAPP variants showed little to no ability to inhibit human IAPP aggregation,\nseveral variants showed some ability to inhibit aggregation, with two variants showing substantial\ninhibitory potential.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> Several naturally occurring IAPP variants capable of inhibiting human IAPP aggregation\nwere identified and characterized.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866528666210806152706","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T04:39:22Z","timestamp":1628483962000},"page":"963-971","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nonhuman IAPP Variants Inhibit Human IAPP Aggregation"],"prefix":"10.2174","volume":"28","author":[{"given":"Alissa","family":"Oakes","sequence":"first","affiliation":[{"name":"Department of Biology, Mount Saint Mary\u2019s University, Los Angeles, CA 90049,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Menefee","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleen","family":"Lamba","sequence":"additional","affiliation":[{"name":"Department of Biology, Mount Saint Mary\u2019s University, Los Angeles, CA 90049,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry M.","family":"Palato","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon J.","family":"Rinauro","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tun","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betssy","family":"Jauregui","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-3494","authenticated-orcid":true,"given":"Luiza A.","family":"Nogaj","sequence":"additional","affiliation":[{"name":"Department of Biology, Mount Saint Mary\u2019s University, Los Angeles, CA 90049,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7430-861X","authenticated-orcid":true,"given":"David A.","family":"Moffet","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Loyola Marymount University, Los Angeles, CA 90045,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1463-1326.2012.01657.x","volume":"14","author":"Montane J.","year":"2012","unstructured":"Montane J.; Klimek-Abercrombie A.; Potter K.J.; Westwell-Roper C.; Bruce Verchere C.; Metabolic stress, IAPP and islet amyloid. Diabetes Obes Metab 2012,14(Suppl. 3),68-77","journal-title":"Diabetes Obes Metab"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.bbamem.2018.02.020","volume":"1860","author":"Asthana S.","year":"2018","unstructured":"Asthana S.; Mallick B.; Alexandrescu A.T.; Jha S.; IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies. Biochim Biophys Acta 2018,1860(9),1765-1782","journal-title":"Biochim Biophys Acta"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e93053","DOI":"10.1371\/journal.pone.0093053","volume":"9","author":"Paulsson J.F.","year":"2014","unstructured":"Paulsson J.F.; Ludvigsson J.; Carlsson A.; High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus. PLoS One 2014,9(3),e93053","journal-title":"PLoS One"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2174\/1389203720666190328111833","volume":"20","author":"Ling W.","year":"2019","unstructured":"Ling W.; Huang Y.M.; Qiao Y.C.; Zhang X.X.; Zhao H.L.; Human amylin: From pathology to physiology and pharmacology. Curr Protein Pept Sci 2019,20(9),944-957","journal-title":"Curr Protein Pept Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.sbi.2012.11.003","volume":"23","author":"Cao P.","year":"2013","unstructured":"Cao P.; Abedini A.; Raleigh D.P.; Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology. Curr Opin Struct Biol 2013,23(1),82-9","journal-title":"Curr Opin Struct Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"Bucciantini M.","year":"2002","unstructured":"Bucciantini M.; Giannoni E.; Chiti F.; Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002,416(6880),507-511","journal-title":"Nature"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"Chiti F.","year":"2006","unstructured":"Chiti F.; Dobson C.M.; Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006,75,333-366","journal-title":"Annu Rev Biochem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/bp060374h","volume":"23","author":"Murphy R.M.","year":"2007","unstructured":"Murphy R.M.; Kendrick B.S.; Protein misfolding and aggregation. Biotechnol Prog 2007,23(3),548-552","journal-title":"Biotechnol Prog"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","volume":"587","author":"Abedini A.","year":"2013","unstructured":"Abedini A.; Schmidt A.M.; Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett 2013,587(8),1119-1127","journal-title":"FEBS Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"17205","DOI":"10.1074\/jbc.M801383200","volume":"283","author":"Apostolidou M.","year":"2008","unstructured":"Apostolidou M.; Jayasinghe S.A.; Langen R.; Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J Biol Chem 2008,283(25),17205-17210","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1210\/jc.2004-0405","volume":"89","author":"Hull R.L.","year":"2004","unstructured":"Hull R.L.; Westermark G.T.; Westermark P.; Kahn S.E.; Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004,89(8),3629-3643","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","volume":"48","author":"Kahn S.E.","year":"1999","unstructured":"Kahn S.E.; Andrikopoulos S.; Verchere C.B.; Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 1999,48(2),241-253","journal-title":"Diabetes"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/jz5001775","volume":"5","author":"Patel H.R.","year":"2014","unstructured":"Patel H.R.; Pithadia A.S.; Brender J.R.; Fierk C.A.; Ramamoorthy A.; In search of aggregation pathways of IAPP and other amyloidogenic proteins: finding answers through NMR spectroscopy. J Phys Chem Lett 2014,5(11),1864-1870","journal-title":"J Phys Chem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3390\/molecules23092142","volume":"23","author":"Moore S.J.","year":"2018","unstructured":"Moore S.J.; Sonar K.; Bharadwaj P.; Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): a review of molecular dynamics simulation studies. Molecules 2018,23(9),2142","journal-title":"Molecules"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"Westermark P.","year":"1990","unstructured":"Westermark P.; Engstrom U.; Johnson K.H.; Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 1990,87(13),5036-5040","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/13506129.2015.1070824","volume":"22","author":"Fortin J.S.","year":"2015","unstructured":"Fortin J.S.; Benoit-Biancamano M.O.; Wildlife sequences of islet amyloid polypeptide (IAPP) identify critical species variants for fibrillization. Amyloid 2015,22(3),194-202","journal-title":"Amyloid"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2337\/diacare.39.1.118","volume":"39","author":"Betsholtz C.","year":"1990","unstructured":"Betsholtz C.; Christmanson L.; Engstrom U.; Rorsman F.; Jordan K.; O'Brien T.D.; Murtaugh M.; Johnson K.H.; Westermark P.; Structure of cat islet amyloid polypeptide and identification of amino-acid-residues of potential significance for islet amyloid formation. Diabetes 1990,39(1),118-122","journal-title":"Diabetes"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e3199","DOI":"10.1002\/psc.3199","volume":"25","year":"2019","unstructured":"Amyloidogenicity of naturally occurring full-length animal IAPP variants. J Pept Sci Palato, L.M.; Pilcher, S; Oakes, A; Lamba, A.; Torres, J.; Ledesma Monjaraz, L.I.; Munoz, C.; Njoo, E.; Rinauro, D.J.; Menefee, K.A.; Tun, A.; Jauregui, B.L.; Shapiro, S.; Nossiff, O.H.; Olivares, E.; Chang, K.; Nguyen, V.; Nogaj, L.A.; Moffet, D.A2019,25(8),e3199","journal-title":"J Pept Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JME-17-0138","volume":"60","author":"Denroche H.C.","year":"2018","unstructured":"Denroche H.C.; Verchere C.B.; IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants. J Mol Endocrinol 2018,60(2),R57-R75","journal-title":"J Mol Endocrinol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0168-8227(92)90071-X","volume":"15","author":"Suzuki S.","year":"1992","unstructured":"Suzuki S.; Murakami M.; Abe S.; Satoh Y.; Shintani S.; Ishizuka J.; Suzuki K.; Thompson J.C.; Toyota T.; The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes. Diabetes Res Clin Pract 1992,15(1),77-84","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0014-5793(00)01287-4","volume":"470","author":"Higham C.E.","year":"2000","unstructured":"Higham C.E.; Jaikaran E.T.; Fraser P.E.; Gross M.; Clark A.; Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett 2000,470(1),55-60","journal-title":"FEBS Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/acs.biochem.5b01107","volume":"55","author":"Wong A.G.","year":"2016","unstructured":"Wong A.G.; Wu C.; Hannaberry E.; Analysis of the amyloidogenic potential of pufferfish (Takifugu rubripes) islet amyloid polypeptide highlights the limitations of thioflavin-t assays and the difficulties in defining amyloidogenicity. Biochemistry 2016,55(3),510-518","journal-title":"Biochemistry"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1006\/jmbi.1999.2646","volume":"287","author":"Kayed R.","year":"1999","unstructured":"Kayed R.; Bernhagen J.; Greenfield N.; Sweimeh K.; Brunner H.; Voelter W.; Kapurniotu A.; Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 1999,287(4),781-796","journal-title":"J Mol Biol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/ijms21124287","volume":"21","author":"Watanabe-Nakayama T.","year":"2020","unstructured":"Watanabe-Nakayama T.; Sahoo B.R.; Ramamoorthy A.; High-speed atomic force microscopy reveals the structural dynamics of the amyloid-beta and amylin aggregation pathways. Int J Mol Sci 2020,21(12),4287","journal-title":"Int J Mol Sci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"e97051","DOI":"10.1371\/journal.pone.0097051","volume":"9","author":"Berhanu W.M.","year":"2014","unstructured":"Berhanu W.M.; Hansmann U.H.; Inter-species cross-seeding: stability and assembly of rat-human amylin aggregates. PLoS One 2014,9(5),e97051","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nchem.1293","volume":"5","author":"Middleton C.T.","year":"2012","unstructured":"Middleton C.T.; Marek P.; Cao P.; Two-dimensional infrared spectroscopy reveals the complex behaviour of an amyloid fibril inhibitor. Nat Chem 2012,5(4),355-360","journal-title":"Nat Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.1021\/jp5022246","volume":"118","author":"Zhang M.","year":"2014","unstructured":"Zhang M.; Hu R.; Liang G.; Chang Y.; Sun Y.; Peng Z.; Zheng J.; Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP. J Phys Chem B 2014,118(25),7026-7036","journal-title":"J Phys Chem B"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1021\/bi301525e","volume":"52","author":"Liang G.","year":"2013","unstructured":"Liang G.; Zhao J.; Yu X.; Zheng J.; Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers. Biochemistry 2013,52(6),1089-1100","journal-title":"Biochemistry"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1021\/jp908436s","volume":"114","author":"Mazzaglia A.","year":"2010","unstructured":"Mazzaglia A.; Micali N.; Scolaro L.M.; Attanasio F.; Magr&#xED; A.; Pappalardo G.; Villari V.; Aggregation properties of the peptide fragments derived from the 17-29 region of the human and rat IAPP: a comparative study with two PEG-conjugated variants of the human sequence. J Phys Chem B 2010,114(2),705-713","journal-title":"J Phys Chem B"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1021\/bi100337p","volume":"49","author":"Fox A.","year":"2010","unstructured":"Fox A.; Snollaerts T.; Casanova C.E.; Selection for nonamyloidogenic mutants of islet amyloid polypeptide (IAPP) identifies an extended region for amyloidogenicity. Biochemistry 2010,49(36),7783-7789","journal-title":"Biochemistry"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1111\/j.1742-4658.2005.05022.x","volume":"272","author":"Gazit E.","year":"2005","unstructured":"Gazit E.; Mechanisms of amyloid fibril self-assembly and inhibition. FEBS J 2005,272(23),5971-5978","journal-title":"FEBS J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1021\/bi8014357","volume":"47","author":"Nanga R.P.","year":"2008","unstructured":"Nanga R.P.; Brender J.R.; Xu J.; Veglia G.; Ramamoorthy A.; Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry 2008,47(48),12689-12697","journal-title":"Biochemistry"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmb.2005.10.052","volume":"355","author":"Abedini A.","year":"2006","unstructured":"Abedini A.; Raleigh D.P.; Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? J Mol Biol 2006,355(2),274-281","journal-title":"J Mol Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1021\/bi0621967","volume":"4611","author":"Marek P.","year":"2007","unstructured":"Marek P.; Abedini A.; Song B.B.; Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology. Biochemistry 2007,4611,3255-3261","journal-title":"Biochemistry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1021\/ja072157y","volume":"129","author":"Abedini A.","year":"2007","unstructured":"Abedini A.; Meng F.L.; Raleigh D.P.; A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor. J Am Chem Soc 2007,129(37),11300","journal-title":"J Am Chem Soc"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1021\/bi051432v","volume":"44","author":"Abedini A.","year":"2005","unstructured":"Abedini A.; Raleigh D.P.; The role of His-18 in amyloid formation by human islet amyloid polypeptide. Biochemistry 2005,44(49),16284-16291","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/protein\/gzm076","volume":"21","author":"Koo B.W.","year":"2008","unstructured":"Koo B.W.; Hebda J.A.; Miranker A.D.; Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. Protein Eng Des Sel 2008,21(3),147-154","journal-title":"Protein Eng Des Sel"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0022-2836(02)00164-X","volume":"318","author":"Scrocchi L.A.","year":"2002","unstructured":"Scrocchi L.A.; Chen Y.; Waschuk S.; Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J Mol Biol 2002,318(3),697-706","journal-title":"J Mol Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"15901","DOI":"10.1021\/bi048812l","volume":"43","author":"Tracz S.M.","year":"2004","unstructured":"Tracz S.M.; Abedini A.; Driscoll M.; Raleigh D.P.; Role of aromatic interactions in amyloid formation by peptides derived from human Amylin. Biochemistry 2004,43(50),15901-15908","journal-title":"Biochemistry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/bi020604a","volume":"42","author":"Park J.Y.","year":"2003","unstructured":"Park J.Y.; Lansbury P.T. Jr.; Beta-synuclein inhibits formation of alpha-synuclein protofibrils: A possible therapeutic strategy against Parkinson\u2019s disease. Biochemistry 2003,42(13),3696-3700","journal-title":"Biochemistry"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1021\/bi020429y","volume":"42","author":"Kessler J.C.","year":"2003","unstructured":"Kessler J.C.; Rochet J.C.; Lansbury P.T.; The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry 2003,42(3),672-678","journal-title":"Biochemistry"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.1021\/bi001315u","volume":"39","author":"Rochet J.C.","year":"2000","unstructured":"Rochet J.C.; Conway K.A.; Lansbury P.T.; Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry 2000,39(35),10619-10626","journal-title":"Biochemistry"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"11970","DOI":"10.1074\/jbc.M109541200","volume":"277","author":"Uversky V.N.","year":"2002","unstructured":"Uversky V.N.; Li J.; Souillac P.; Millett I.S.; Doniach S.; Jakes R.; Goedert M.; Fink A.L.; Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 2002,277(14),11970-11978","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13340-018-0347-1","volume":"9","author":"Kanatsuka A.","year":"2018","unstructured":"Kanatsuka A.; Kou S.; Makino H.; IAPP\/amylin and beta-cell failure: implication of the risk factors of type 2 diabetes. Diabetol Int 2018,9(3),143-157","journal-title":"Diabetol Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41467-020-20454-z","volume":"12","author":"Kim J.","year":"2021","unstructured":"Kim J.; Park K.; Kim M.J.; An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer. Nat Commun 2021,12(1),183","journal-title":"Nat Commun"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866528666210806152706","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195384\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866528666210806152706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T18:47:39Z","timestamp":1660416459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195384\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866528666210806152706","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}